Israël – Pharmaseed to open spin-off in France

July 23, 2014 2:12 pm0 commentsViews: 78

Source : Google

Pharmaseed is an Israeli company specializing in translational preclinical studies for fifteen years helping universities, incubators and Israeli start-ups to translate their technological innovations in pharmaceuticals.

With the expertise gained, Pharmaseed opens a spin-off in France, the 4P-Pharma laboratory. 4P-Pharma is a biotechnology company that transforms discoveries from institutes and universities French renamed therapeutic. “We will create value by four evidence: evidence of the mechanism, in principle, concept and relevance,” says Revital Rattenbach, Director of 4P Pharma who gave this information in preview Israel Science Info.

As a preview of MIXiii Biomed 2014 Pharmaseed had told Israel Science Info agreement signed with the Arava R & D center at the Dead Sea (Israel).

Since Pharmaseed has built a strong expertise in early preclinical development, regulation and safety of pharmaceuticals R & D center has developed Arava relying in particular on the activities of the cosmetics company Ahava and acquired a sharp mastery of local natural resources.

Today, the issue of the effectiveness and safety of dermatological products is still very present. This is to address this issue that the partnership between Pharmaseed and Arava was born. Objective: To develop innovative research tools that integrate the efficacy and safety for the treatment of skin diseases such as psoriasis. Near Masada, a high-tech center with environmental standards is under construction which will work specialists and technologies of the most prestigious universities, and where the famous bacteria, minerals and natural local products will be used and developed. “Soon, the lowest place on earth (Dead Sea) will have the world’s highest skills,” says Dr. Lamensdorf.

[Source : israelvalley]

Comment this Post

You must be logged in to post a comment.

Recent Comments

    Tags